All data are based on the daily closing price as of July 18, 2025
n
Nippon Shinyaku
4516.TSE
20.91 USD
-0.13
-0.62%
Overview
Last close
20.91 usd
Market cap
1.41B usd
52 week high
33.61 usd
52 week low
17.41 usd
Target price
28.77 usd
Valuation
P/E
6.4309
Forward P/E
12.9199
Price/Sales
1.3069
Price/Book Value
0.8477
Enterprise Value
1.03B usd
EV/Revenue
0.9589
EV/EBITDA
3.6328
Key financials
Revenue TTM
1.08B usd
Gross Profit TTM
733.16M usd
EBITDA TTM
288.54M usd
Earnings per Share
3.25 usd
Dividend
0.83 usd
Total assets
1.90B usd
Net debt
-352.26M usd
About
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. Its Pharmaceuticals Business segment offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases. The company's Functional Food Business segments provides health food ingredients, preservatives, protein preparations, and sports and supplements. The company in the Strategic Partnership with Nippon Shinyaku will develop and commercialize for Mucopolysaccharidosis. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.